← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Avi Biopharma, Inc.
Corvallis, OR
$3,076,614
Total funding
7
Grants
Funding over time
peak $694.6K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$3,076,614 · 7
By mechanism
R42$2,099,425 · 2
R43$813,111 · 4
R41$164,078 · 1
Investigators at Avi Biopharma, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Upregulation of soluble TNFR2 as treatment for Rheumatiod Arthritis$694,600
R42 · FY2009 · AR
Upregulation of soluble TNFR2 as treatment for Rheumatiod Arthritis$650,934
R42 · FY2008 · AR
THERAPEUTIC APPLICATIONS OF MICROBUBBLES-PHASE II$424,266
R42 · FY2000 · HL
Antisense Antiviral Agent for West Nile Infections$364,696
R43 · FY2005 · AI
THERAPEUTIC APPLICATIONS OF MICROBUBBLES-PHASE II$329,625
R42 · FY2001 · HL
Inhibition of Androgen Receptor to treat Prostate Cancer$250,000
R43 · FY2003 · CA
Morpholino Antisense Drugs for Hepatitis C Virus$164,078
R41 · FY2004 · DK
Antisense Morpholino Oligomers to Treat Retinopathy$100,000
R43 · FY2003 · EY
INHIBITION OF C-MYC TO TREAT POLYCYSTIC KIDNEY DISEASE$98,415
R43 · FY2000 · DK